Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...

Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III EXPLORER-HCM trial has demonstrated that the novel cardiac myosin inhibitor ...

Cardiac arrhythmias are one of cardiology’s major current challenges. They occur when the heart rhythm becomes irregular, too fast, or too slow, affecting both quality of life and survival. An ...

Shopping. Traveling. Planning family gatherings. The stress of the holiday season can make you feel like you need to slip some spirits into your hot cocoa. And at celebrations, there's often plenty of ...

Detailed histological examination of the conduction system in 29 cases of acute myocardial infarction complicated by heart block has been carried out. In 24 cases posterior infarction was present and ...

New research in Sweden has produced a "blueprint" revealing how the human heart is built during prenatal development. It offers insights that could lead to improved prenatal care and new treatments ...

CINCINNATI, Ohio – We’ve all heard warnings about BPA, a chemical found in plastics and personal care products. Studies show that nearly 90% of Americans have detectable levels of BPA in their bodies.

Can a newer, more targeted pacing method revolutionize heart failure treatment? The PhysioSync-HF trial investigates conduction system pacing as a potentially more effective and affordable alternative ...

Sept. 25 (UPI) --Researchers have succeeded in creating a digital twin that for the first time replicates the heart's electrical conduction system, which coordinates heartbeats, a new study says. The ...

Patients with atrioventricular (AV) block who don’t have an indication for cardiac resynchronization therapy (CRT) do better when treated with conduction-system pacing versus right ventricular septal ...